G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. (Q53485275)
Jump to navigation
Jump to search
scientific article published on 24 April 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. |
scientific article published on 24 April 2007 |
Statements
G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. (English)
Martin S Tallman
1 reference
Mrinal Gounder
Jeffrey Cilley
Taylor Ortiz
Nanjiang Hou
Alfred Rademaker
Sarah Miyata
Kara Catsaros
Connie Augustyniak
Charles L Bennett
Daina Variakojis
Jane N Winter
24 April 2007
545-552
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference